Dr. Sarthak Kumar Mohanty Radiation Oncologist in Rajkot

Dr. Sarthak Kumar Mohanty

Radiation Oncologist, Rajkot

MBBS, MD

  • 16 Years Experience
  • 1 Hospital

About

MD, Radiation Onlology, AHRCC, Cuttack; Fellowship in IMRT & IGRT in TMH, Mumbai ; UICC Fellow at University of Michigan , USA
Huge experience in Oncology of more than 13 years;
He can able do All the Modern radiation Oncology Techniques such as 3DCRT, IMRT, IGRT, Rapid Arc, SRS, SBRT, SRT and other motion management solutions, Brachytherapy.
  • Languages : English, Hindi, Gujarati

Experience

CONSULTANT RADIATION ONCOLOGIST , Shri Nathalal Cancer Institute , Rajkot June, 2013 -  January, 2020

Specialities

  • Radiation Oncology

Procedures

  • Cancer Treatment

  • Chemotherapy

  • External Beam Radiotherapy

  • Image-Guided Radiation Therapy (IGRT)

  • Intensity-Modulated Radiation Therapy (IMRT)

Conditions

  • Adenocarcinoma

  • Adrenal Tumor

  • Adult Small Cell Lung Cancer

  • Anal and Rectal Cancer

  • Bladder Cancer

Expertise

More than 13 years in the field of Oncology
Capable of doing All the modern Radiation Technologies such as 3DCRT, IMRT, IGRT, Rapid arc, SRS, SBRT, SRT, Brachytherapy etc.

Education

MD, 2011, AHRegional Cancer Center, Cuttack , India

MBBS, 2006, MKCG Medical college, Berhampur, India

Fellowship in IMRT & IGRT, 2013, Tata Memorial Hospital , Mumbai , India

UICC Fellowship, 2017, University of Michigan, Ann Arbor, USA

Varian school of Motion management , 2014, Marie Curie Cancer Hospital, Poland

Practice Information

Sterling Hospital, Ahmedabad

Sterling Hospital, Ahmedabad

Sterling Hospital Road, Memnagar, Ahmedabad, Gujarat - 380052

MON, TUE, WED, THU, FRI, SAT

09:30 AM - 05:30 PM

Achievements & Contributions

  • Do not Delay Your Cancer treatments during Corona.
  • Correlation of conventional magnetic resonance imaging features with O6-methylguanine-DNA-methyltransferase gene promoter methylation status and survival outcomes in patients with newly diagnosed glioblastoma
  • A comparative analysis of quality of life after postoperative intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for cervical cancer
  • Prospective longitudinal assessment of sensorineural hearing loss with hyperfractionated radiation therapy alone in patients with average-risk medulloblastoma
  • Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: A clinical audit
  • QOL in women undergoing adjuvant or salvage IMRT for cervical cancer – Poster discussion
  • Dose-volume correlation of cumulative vaginal doses and late toxicity after adjuvant external radiation and brachytherapy for cervical cancer
  • Commentary on SCALOP trial : A multicentre, randomized phase II trial,
  • Scroll Of Honour for Fellowship in IMRT and IGRT
  • AROI
  • IAPC
  • IMA

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Sarthak Kumar Mohanty and his staff know how they are doing and how they can improve their services.